Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Radivoyevitch

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Blood Cancer Journal|December 17, 2016
The complexity of interpreting genomic data in patients with acute myeloid leukemiaA Nazha, A Zarzour, K Al-Issa, et al.
Leukemia|June 25, 2011
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemiaK P Ng, Q Ebrahem, S Negrotto, et al.
Leukemia|August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomideE Negoro, T Radivoyevitch, C Polprasert, et al.
Leukemia|August 19, 2017
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromesA Nazha, K Al-Issa, B K Hamilton, et al.
Leukemia|November 7, 2017
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodineR J Molenaar, C Pleyer, T Radivoyevitch, et al.
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Leukemia|November 4, 2017
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasiaH Sakai, N Hosono, H Nakazawa, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood Cancer Journal|December 17, 2016
The complexity of interpreting genomic data in patients with acute myeloid leukemiaA Nazha, A Zarzour, K Al-Issa, et al.
Leukemia|June 25, 2011
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemiaK P Ng, Q Ebrahem, S Negrotto, et al.
Leukemia|August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomideE Negoro, T Radivoyevitch, C Polprasert, et al.
Leukemia|August 19, 2017
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromesA Nazha, K Al-Issa, B K Hamilton, et al.
Leukemia|November 7, 2017
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodineR J Molenaar, C Pleyer, T Radivoyevitch, et al.
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Leukemia|November 4, 2017
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasiaH Sakai, N Hosono, H Nakazawa, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 3